See also this year's filing and all EDGAR filings for this company.
PDF Report 0001130598_2018_Onconova_Therapeutics_Inc.pdf
Logs
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001130598')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001130598, Onconova Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 4,903,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 64,000 |
| 3 | remainder_Assets | 12,000 |
| 4 | LiabilitiesCurrent | 9,976,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 5,864,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 7,405,000 |
| 9 | ResearchAndDevelopmentExpense | 19,119,000 |
| 10 | remainder_Expenses | -1,615,000 |
| 11 | remainder_Revenues | 787,000 |
| 12 | remainder_NetIncome | 30,000 |
| 13 | remainder_ComprehensiveNetIncome | 34,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 4,979,000 |
| 1 | Liabilities | 15,840,000 |
| 2 | Expenses | 24,909,000 |
| 3 | Revenues | 787,000 |
| 4 | StockholdersEquity | -10,861,000 |
| 5 | NetIncome | -24,092,000 |
| 6 | ComprehensiveNetIncome | -24,075,000 |
| 7 | BaseVar | 23,289,500 |
| 8 | EconomicCapitalRatio | -4.11 |
Edgar->Model Mapping
Feature Distribution
Change over Time
